Popular Articles From: Fairfax Announces Reset Dividend Rate on Its Series C Preferred Shares to Stock Market Outlook: Keep Your Expectations in Check


http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0982164001&sourceType=1 http://www.ccnmatthews.com/logos1/Fairfax.gif TORONTO, ONTARIO --
Sign-up for Fairfax Announces Reset Dividend Rate on Its Series C Preferred Shares investment picks
http://media.marketwire.com/attachments/200903/512688_IKA_Logo_3C_RGB.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1162159&ProfileId=051205&sourceType=1 FREMONT, CA --
Sign-up for Ikanos Communications Announces Commencement of Rights Offering to Stockholders investment picks
- Former Chair Jerry Grundhofer retires - Mr.
Sign-up for Santander Names T. Timothy Ryan, Jr. As Chairman Of Santander Holdings USA And Santander Bank, N.A. investment picks
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today the presentation of results from the company’s Phase 1 trial of EPZ-5676, a potent and selective inhibitor of the DOT1L histone methyltransferase (HMT). Epizyme, along with its partner Celgene, is developing EPZ-5676 for the treatment of acute leukemia with alterations in the MLL gene (MLL-r) or partial tandem duplications within MLL (MLL-PTD). The trial found that EPZ-5676 was generally safe and well tolerated across all dose cohorts and showed clinical and biological activity.
Sign-up for Epizyme DOT1L Inhibitor EPZ-5676 Shows Clinical and Biological Activity in Adult Patients with Acute Leukemias in Phase 1 Trial investment picks
Avigilon Appoints Dennis Fong to Vice President of Investor Relations Canada NewsWire VANCOUVER , Jan.
Sign-up for Avigilon Appoints Dennis Fong to Vice President of Investor Relations investment picks
Biogen Idec (NASDAQ: BIIB) today announced top-line results from the Phase 2 acute optic neuritis (AON) RENEW trial in which treatment with anti-LINGO-1 showed evidence of biological repair of the visual system.
Sign-up for Biogen Idec Reports Positive Top-Line Results from Phase 2 Anti-LINGO-1 Trial in People with Acute Optic Neuritis investment picks
2015/1/6
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0986546001&sourceType=1 http://media3.marketwire.com/logos/20140717-DREAM%20OFFICE%20200.jpg TORONTO, ONTARIO --
Sign-up for Dream Office REIT Announces Strong Fourth Quarter Leasing and Update on Repurchase of REIT A Units investment picks
2015/1/6
By Ryan Knutson Verizon Communications Inc. Chief Executive Lowell McAdam said the telecom giant isn't in talks to buy AOL Inc., and that he is more likely to enter partnerships with media companies than try to acquire them as Verizon builds out its video business.
Sign-up for Verizon CEO Dismisses Deal Talk, Seeks Media Partnerships investment picks
2015/1/6
By Gaurav Raghuvanshi And Richard C.
Sign-up for AirAsia Flight 8501 Crash: Time Running Out to Recover Floating Bodies -- 3rd Update investment picks
By Tess Stynes Amgen Inc. and Kite Pharma Inc. reached a research collaboration and license agreement to develop cancer immunotherapy treatments that focus on Amgen's array of cancer targets and Kite Pharma's autologous cell therapy platform.
Sign-up for Amgen and Kite Pharma in cancer immunotherapy pact investment picks
Andrews & Springer LLC , a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of The Pantry, Inc. (NASDAQ: PTRY) (“Pantry” or the “Company”) relating to the sale of the Company to Alimentation Couche-Tard Inc. (“Couche-Tard”). On December 18, 2014, the two companies announced the signing of a definitive merger agreement pursuant to which Couche-Tard will acquire Pantry in a merger worth $1.7 billion (including debt). As a result of the merger, Pantry shareholders are only anticipated to receive $36.75 per share in cash in exchange for each share they own.
Sign-up for PANTRY (PTRY) MERGER INVESTIGATION ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of The Pantry, Inc. investment picks
2015/1/1
By Patrick McGroarty and Drew Hinshaw Global health experts are preparing to test new treatments for Ebola in West Africa that they hope will eventually vanquish the hemorrhagic fever.
Sign-up for Experts Rush to Find Ebola Treatments in 2015 investment picks
By Silvia Ascarelli, MarketWatch NEW YORK (MarketWatch) -- Bill Gates is back with a list of his favorite reads from 2014.
Sign-up for UPDATE: The five best books Bill Gates read in 2014 investment picks
Colony Financial, Inc. ( NYSE: CLNY ) and the parent company of its manager, Colony Capital, LLC (“ Colony Capital ”), today announced that the parties have signed a definitive agreement for the contribution to CLNY of substantially all of Colony Capital’s real estate and investment management businesses and operations for an aggregate potential consideration of up to $657.5 million (the “ Proposed Transaction ”), to be paid in a combination of shares of CLNY common stock and membership interests in a subsidiary of CLNY that will hold CLNY’s business and operations, and otherwise on terms consistent with the non-binding agreement in principle jointly announced by the parties on November 4, 2014.
Sign-up for Colony Financial, Inc. to Combine with Colony Capital, LLC investment picks
2014/12/15
The University of Texas MD Anderson Cancer Center and UnitedHealthcare have launched a pilot to explore a new cancer care payment model for head and neck cancers that focuses on quality patient care and outcomes.
Sign-up for MD Anderson, UnitedHealthcare Launch New Cancer Care Payment Model investment picks
EverBank Financial Corp (NYSE: EVER) announced today that it will release its financial results for the fourth quarter ended December 31, 2014, prior to the market open on Wednesday, January 28, 2015, to be followed by a conference call at 8:30 a.m. ET the same day.
Sign-up for EverBank Financial Corp Announces Fourth Quarter 2014 Earnings and Conference Call Date investment picks
Northern Blizzard Resources Inc. Announces Revised 2015 Capital Program & Guidance; Maintains Dividend Canada NewsWire CALGARY , Dec.
Sign-up for Northern Blizzard Resources Inc. Announces Revised 2015 Capital Program & Guidance; Maintains Dividend investment picks
Silicon Imaging's (SIMG) activist investor Engaged Capital, which said it increased its stake in the semiconductor company to 5.2%, said the company's stock was trading at a 48% to 116% discount based on a sum-of-the-parts analysis.
Sign-up for Silicon Imaging investor Engaged said company is 48% to 116% undervalued investment picks
Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.36 per ordinary share.
Sign-up for Covidien Declares Quarterly Cash Dividend investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1166053&ProfileId=051205&sourceType=1 DENVER, CO --
Sign-up for Advanced Cannabis Solutions Signs Master Services Agreement With Spector Group II, LLP for Build Out of "The Greenhouse" investment picks
2014/12/16
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0984226001&sourceType=1 http://www.ccnmatthews.com/logos2/talisman_logo.gif CALGARY, ALBERTA --
Sign-up for Repsol to Acquire Talisman Energy for US$8.00 Per Common Share In All-Cash Transaction investment picks
2014/12/15
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0983677001&sourceType=1 http://www.ccnmatthews.com/logos/20070727-tel0727.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for CraveTV(TM) Lands on TELUS Optik TV investment picks
2015/1/9
Jaguar Mining to Attend Cambridge Vancouver Resource Investment Conference - January 18-19, 2015 Canada NewsWire TSX-V: JAG TORONTO , Jan.
Sign-up for Jaguar Mining to Attend Cambridge Vancouver Resource Investment Conference - January 18-19, 2015 investment picks
2014/09/29
Current valuation levels imply mediocre total returns and an elevated risk of a material drawdown.
Sign-up for Stock Market Outlook: Keep Your Expectations in Check investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Popular Articles From: Fairfax Announces Reset Dividend Rate on Its Series C Preferred Shares to Stock Market Outlook: Keep Your Expectations in Check
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent